使用三维1060纳米光学相干断层扫描绘制单侧非肉芽肿性急性前葡萄膜炎的视网膜和脉络膜厚度图
本研究使用三维1060纳米光学相干断层扫描分析24例新诊断单侧非肉芽肿性急性前葡萄膜炎患者的视网膜厚度和脉络膜厚度变化,其中17例随访至炎症消退。结果显示治疗前患眼脉络膜较对侧眼显著增厚,平均厚度差为37±11.44微米,治疗后脉络膜厚度显著降低,平均变化为24±6.9微米;视网膜厚度在治疗前后及患眼与对侧眼间均无显著差异。
要点
- 治疗前急性前葡萄膜炎患眼脉络膜较对侧眼显著增厚,平均厚度差37±11.44微米。
- 治疗后脉络膜厚度显著降低,平均变化24±6.9微米。
- 视网膜厚度在治疗前患眼与对侧眼间及治疗前后均无显著差异。
核心结论
- 急性前葡萄膜炎患眼治疗前脉络膜厚度增加、治疗后降低,而视网膜厚度似乎不受疾病和治疗影响。
- 脉络膜厚度可能作为监测急性前葡萄膜炎患者后节受累和治疗反应的有用生物标志物。
研究设计与样本
- 对24例新诊断单侧非肉芽肿性急性前葡萄膜炎患者,在治疗前使用三维1060纳米光学相干断层扫描进行视网膜和脉络膜厚度图统计分析。
- 其中17例随访至炎症活动消退,消退在初次诊断后6周内发生于所有受试者,消退后再次生成厚度图。
- 所有患者均使用高速谱域三维1060纳米光学相干断层扫描在10×10毫米视野内成像,并使用早期治疗糖尿病视网膜病变研究网格对厚度空间分布进行映射和分析。
主要发现
- 治疗前急性前葡萄膜炎患眼脉络膜较对侧眼显著增厚,平均厚度差为37±11.44微米(均值±标准差,Bonferroni校正,α=0.0125)。
- 治疗后脉络膜厚度显著降低,平均变化为24±6.9微米(均值±标准差,Bonferroni校正,α=0.0125)。
- 治疗前急性前葡萄膜炎患眼与对侧眼之间以及治疗前后急性前葡萄膜炎患眼之间,视网膜厚度均无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To analyze retinal thickness (RT) and choroidal thickness (ChT) changes in patients with unilateral nongranulomatous acute anterior uveitis (AAU) using three-dimensional (3D) 1060-nm optical coherence tomography (OCT). METHODS: Retinal and choroidal thickness maps were statistically analyzed for 24 patients with newly diagnosed unilateral AAU before therapy. A total of 17 patients were followed until resolution of inflammatory activity (twice in the first week, then weekly). Resolution occurred in all subjects within 6 weeks after the initial diagnosis. After resolution, thickness maps were again generated. All patients were imaged by high-speed spectral-domain (SD) 3D 1060-nm OCT over a 10 × 10-mm field of view. The spatial distribution of retinal and choroidal thickness was mapped and analyzed using the Early Treatment Diabetic Retinopathy Study (ETDRS) grid. RESULTS: The choroid was significantly thicker in eyes affected by AAU than in fellow eyes before therapy with a mean thickness difference of 37 ± 11.44 μm (mean ± SD, Bonferroni correction, α = 0.0125). Following therapy, ChT significantly decreased with a mean change of 24 ± 6.9 μm (mean ± SD, Bonferroni correction, α = 0.0125). There was no significant difference in RT between AAU and fellow eyes before therapy or in AAU eyes before and after therapy. CONCLUSIONS: Eyes affected by AAU demonstrate an increase in ChT before and a subsequent decrease after therapy while retinal thickness seems unaltered by disease and therapy. ChT might be a useful biomarker in monitoring posterior involvement and response to therapy in patients with AAU.
引用
- Gabriel M, Kruger R, Shams-Mafi F, et al. Mapping Retinal and Choroidal Thickness in Unilateral Nongranulomatous Acute Anterior Uveitis Using Three-Dimensional 1060-nm Optical Coherence Tomography. Invest Ophthalmol Vis Sci. 2017. PMID: 28973324. doi:10.1167/iovs.17-22265
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。